News

Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization in the United States solely dedicated to the myasthenia gravis (MG) community, announced the ...
SOURCE Myasthenia Gravis Foundation of America, Inc. The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties.
Myasthenia Gravis Epidemiology Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted myasthenia gravis epidemiology in the 7MM, i.e., the United ...
The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis who are anti-acetylcholine receptor or anti-muscle-specific kinase ...
About 80%-90% of patients with generalized myasthenia gravis (gMG) have anti-AChR antibodies, and they’re the ones being targeted in UCB’s campaign. “Most commonly, gMG impacts women 30-50 ...
Nicholas J. Silvestri, MD, recounts how the 2025 American Academy of Neurology meeting was an exciting and energizing event, particularly in the realm of myasthenia gravis (MG), where numerous new ...
People who suffer from the autoimmune disease myasthenia gravis experience muscle weakness that can affect any of the muscles we use to blink, smile or even move our body around.
500 attendees in Phoenix, Arizona to educate and inform the MG community. PHOENIX, March 31, 2025 /PRNewswire/ -- More than 500 members of the myasthenia gravis (MG) rare disease community will ...
This autoimmune disorder affects how well your nerves and muscles communicate, leading to a variety of symptoms. Myasthenia gravis (MG) is a chronic autoimmune condition that affects signaling ...
The FDA has approved Soliris the first-ever treatment for children with generalized myasthenia gravis gMG offering new hope in pediatric neuromuscular care Learn more!
No swallow or voice evaluation or treatment were offered to 83.1% of all individuals with myasthenia gravis, 53% of patients with myasthenia gravis and any speech/swallow dysfunction, 43.8% who ...
AChR-Abs, which impact the communication between nerves and muscles, are commonly found in patients with myasthenia gravis via a blood test. 2 However, the relationship between AChR-Ab titer and ...